The most widely used treatment for RA includes corticosteroids [31], nonsteroidal [39] anti-inflammatory drugs (NSAIDs), nonbiologic [40] disease-modifying antirheumatic drugs (DMARDs), and biologic DMARDs [41, 42] like anti-TNF-α monoclonal antibodies [42], which are aimed at reducing the symptoms and gradually alleviating the disease pathogenesis. Here, TNF is linked to rheumatoid arthritis.